|
시장보고서
상품코드
1457956
세계의 멀티플렉스 어세이 시장 : 시장 규모, 점유율 분석, 산업 수요 예측(-2030년)Multiplex Assays Market Size and Share Analysis by Product, Type, Technology - Global Industry Demand Forecast to 2030 |
||||||
세계의 멀티플렉스 어세이(Multiplex Assays) 시장은 2023년에는 39억 1,800만 달러였으며, 9.0%의 CAGR로 추이하며 성장하여, 2030년에는 71억 350만 달러에 달할 것으로 예상됩니다.
이 배경에는 만성 질환과 감염의 급증이 있습니다. 또한 연구자, 환자, 의료 제공업체의 지출을 줄이기 위해 연구 및 임상 진단에서 개발된 분석 플랫폼에 대한 수요가 증가하고 있는 것도 주요 요인입니다.
부문별 분석
제품별로 보면 2023년에는 소모품 카테고리가 45%의 점유율로 업계를 선도했습니다. 이는 진단검사수 증가와 생명과학기업에 의한 연구활동 증가에 따른 것입니다.
기술별로는 멀티플렉스 실시간 PCR 카테고리가 향후 수년간 9.4%로 가장 빠른 속도로 진보할 것으로 보입니다. 이는 PCR 시스템의 다양한 변형이 신속하게 출시되기 때문입니다.
아시아 태평양이 급성장지역
아시아 태평양이 가장 빠른 속도로 진보하고 있는 이유는 병원 수가 증가하고 산업에 대한 투자액이 증가하고 정비된 의료 인프라에 대한 높은 요구 때문입니다. 또한 중국은 지역 내에서 가장 빠르게 성장하는 국가입니다.
북미는 2023년에 55%의 점유율을 차지하고, 이 업계에서 가장 큰 점유율을 차지하며, 향후 몇 년간 크게 전진할 것으로 보입니다. 이는 신약 및 진단 솔루션 개발을 위한 제약회사와 생명공학기업의 연구개발 활동이 활발해지고 있기 때문입니다.
세계의 멀티플렉스 어세이(Multiplex Assays) 시장에 대해 분석했으며, 시장의 기본 구조/최신 정세/주요 촉진·억제 요인/세계 전체 및 지역별·주요 국가 시장 규모 동향 전망(금액 기준, 2017-2030년) 제품별·유형별·기술별 상세 동향/현재 시장 경쟁 구도/주요 기업 프로파일 등 정보를 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 산업 전망
- 시장 역학
- 동향
- 성장 촉진 요인
- 억제 요인/과제
- 성장 촉진 요인/억제 요인의 영향 분석
- COVID-19의 영향
- Porter's Five Forces 분석
제6장 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아 태평양 시장
제10장 남미 시장
제11장 중동 및 아프리카(MEA) 시장
제12장 미국 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 진출기업 및 제공 제품 및 서비스 목록
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근의 전략 전개 상황
제30장 기업 프로파일
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Bio-Rad Laboratories Inc.
- Qiagen NV
- Abcam plc
- Becton, Dickinson and Company
- Merck KGaA
- Agilent Technologies Inc.
- Meso Scale Diagnostics LLC
제31장 부록
LYJ 24.04.16The multiplex assays market was USD 3,918.0 million in 2023, which will reach USD 7,103.5 million, powering at a 9.0% CAGR, by 2030.
This is because of the surging incidence of chronic ailments as well as infectious diseases. Furthermore, the rising demand for developed analytical platforms in research and clinical diagnostics, to decrease the expenses for researchers, patients, and healthcare providers is also a key contributor.
According to the World Health Organization, chronic diseases including cancer, cardiovascular diseases, respiratory illnesses, and diabetes, will account for 86% of the 90 million deaths annually by around 2050, a significant increase of 90% since 2019.
Moreover, there were an estimated 249 million cases of malaria and 608,000 deaths from this disease in 85 nations in 2022. In addition, in the same year, there were around 39 million individuals with HIV globally. Of these, 1.5 million were children (below 15 years of age), and 37.5 million were adults. Additionally, 53% were girls and women.
The COVID-19 pandemic has had a positive impact on the industry, by driving an enormous rise in research & development for the production of innovative solutions to detect coronavirus.
Furthermore, the surging elderly population and incidence of autoimmune ailments, cancer, and human immunodeficiency virus are likely to drive the industry growth during this decade.
Segmentation Insights
The consumables category, based on product, led the industry in 2023, with a 45% share. This is because of the increasing count of diagnostic tests and the rising research activities by life sciences businesses.
For example, in January 2023, Novo Nordisk, a pharmaceutical firm, declared a grant of USD 6 million for Durham Technical Community College.
The grant is to assist the latter's life sciences program and build a new 35,000-square-foot training center.
In 2023, the protein-based category, based on type, accounted for the largest share, of 50%, owing to the rising adoption of such products in proteomics studies. Furthermore, protein-based assays are extensively employed in research to classify the concentration of electrophoresis, cell biology, protein, and various other analytes.
The multiplex real-time PCR category, based on technology, is likely to advance at the fastest rate, of 9.4%, in the years to come. This can be ascribed to the swift launch of different variants of PCR systems.
APAC is Fastest-Growing Region
APAC is advancing at the fastest rate, because of the increasing number of hospitals, rising investment value in this industry, and high requirement for developed healthcare infrastructure. In addition, China is the fastest-growing nation in APAC.
North America was the largest contributor to the industry in 2023, with a 55% share, and it will advance significantly in the years to come. This is because of the increasing research & development activities by pharmaceutical and biotechnology firms to develop new drugs as well as diagnostic solutions.
Competition Analysis
Key players are highly focused on investments and innovations to develop panels and devices for the multiplexed detection of the virus. Also, businesses are engaging in partnerships to distribute immunometric assays.
Oxford Nanopore Technologies and 10x Genomics, in October 2022, announced a partnership to develop an efficient workflow for full-length transcript sequencing in a single read on the devices of Oxford Nanopore.
This partnership enables the integration of Oxford's Promethlon devices as well as sample preparation on 10x Genomics devices, along with selected consumables.
With the surging incidence of infectious and chronic diseases, the multiplex assays industry will grow continuously in the coming years.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by type
- 1.4.3. Market size breakdown, by technology
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product (2017-2030)
- 6.3. Market Revenue, by Type (2017-2030)
- 6.4. Market Revenue, by Technology (2017-2030)
- 6.5. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Type (2017-2030)
- 7.4. Market Revenue, by Technology (2017-2030)
- 7.5. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Type (2017-2030)
- 8.4. Market Revenue, by Technology (2017-2030)
- 8.5. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Type (2017-2030)
- 9.4. Market Revenue, by Technology (2017-2030)
- 9.5. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Type (2017-2030)
- 10.4. Market Revenue, by Technology (2017-2030)
- 10.5. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Type (2017-2030)
- 11.4. Market Revenue, by Technology (2017-2030)
- 11.5. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Type (2017-2030)
- 12.4. Market Revenue, by Technology (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Type (2017-2030)
- 13.4. Market Revenue, by Technology (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Type (2017-2030)
- 14.4. Market Revenue, by Technology (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Type (2017-2030)
- 15.4. Market Revenue, by Technology (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Type (2017-2030)
- 16.4. Market Revenue, by Technology (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Type (2017-2030)
- 17.4. Market Revenue, by Technology (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Type (2017-2030)
- 18.4. Market Revenue, by Technology (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Type (2017-2030)
- 19.4. Market Revenue, by Technology (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Type (2017-2030)
- 20.4. Market Revenue, by Technology (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Type (2017-2030)
- 21.4. Market Revenue, by Technology (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Type (2017-2030)
- 22.4. Market Revenue, by Technology (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Type (2017-2030)
- 23.4. Market Revenue, by Technology (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Type (2017-2030)
- 24.4. Market Revenue, by Technology (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Type (2017-2030)
- 25.4. Market Revenue, by Technology (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Type (2017-2030)
- 26.4. Market Revenue, by Technology (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Type (2017-2030)
- 27.4. Market Revenue, by Technology (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Type (2017-2030)
- 28.4. Market Revenue, by Technology (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Thermo Fisher Scientific Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Illumina Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Bio-Rad Laboratories Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Qiagen N.V.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Abcam plc
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Becton, Dickinson and Company
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Merck KGaA
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Agilent Technologies Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Meso Scale Diagnostics LLC
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
